CureMatch Articles & News
Phil Trubey, founder of the successful computer security company WebSense (now ForcePoint), has written an op-ed in the Rancho Santa Fe Post entitled “Got Cancer? Try CureMatch.” The article discusses the benefits of personalized medicine and the CureMatch report.
An in vitro study was performed that illustrates the benefit of CureMatch’s personalized combination therapy approach. The experiment used cancer cell lines that were derived from the tumors of patients. In the study, CureMatch used cell lines from human pancreatic adenocarcinoma tumors with eight mutations, two of which were deemed “actionable” – meaning that the CureMatch platform determined that […]
This case study describes a patient with basal cell carcinoma who was given four lines of treatment that were unsuccessful. A personalized approach was subsequently taken, and a beta version of the CureMatch Decision Support System platform was used to guide in the selection of immunotherapy, leading to near complete remission.
WebMD Video highlights immunotherapy findings that have been incorporated into the CureMatch analytic platform. SAN DIEGO, CA – March 30, 2017 – WebMD has produced a new video, entitled “The Genesis of Immunotherapy” that features CureMatch Co-Founder and Chief Medical Advisor, Razelle Kurzrock, MD. The video, from this WebMD video series “Immunotherapy for Cancer: A New […]
The Rancho Santa Fe News interviews CureMatch CEO Blaise Barrelet to discuss his personal battle with Leukemia and the motivation behind the founding of CureMatch. Rancho Santa Fe Resident Launches Company to Provide Personalized Cancer Care By: Karen Billing Rancho Santa Fe resident Blaise Barrelet recently launched CureMatch, a new company he believes could be the […]
